×
We have detected your country as:
Please click here to go to the USA website or select another country from the dropdown list.
We have detected your country as:
Please click here to go to the USA website or select another country from the dropdown list.
Artificial pancreas—People who have diabetes must check their blood-sugar level every few hours throughout the day and night, to determine when and how much insulin is needed to balance it. A new artificial pancreas developed at Schneider Children’s Medical Center in Tel Aviv could make this task automatic. For more information: http://www.schneider.org.il/Eng/Index.asp
DiaPep 277—The largest and most advanced study ever involving Type 1 diabetes patients is centered around an insulin alternative developed at Israel’s Andromeda Biotech. The synthetic peptide DiaPep277 seems to halt the progression of this form of the disease, in which a haywire immune response actually kills the insulin-producing beta cells in the pancreas. Final clinical results are expected in 2014. For more information: http://www.andromedabio.com
Medical smartphone—LifeWatch V, the world’s first medical smartphone, is an Android-based phone with embedded sensors to analyze everything from blood glucose levels to body fat percentage. Blood-glucose test strips can be inserted into a portal on the phone’s stainless-steel frame, and results are automatically and securely sent to a remote server for analysis. Results are quickly shared with the user and/or a parent or healthcare provider via email or text message. Now in the process of regulatory approvals in Israel, LifeWatch V was designed to be user-friendly for anyone from children to seniors. Young diabetes patients are a core target group because the device will help parents monitor their children’s daily testing and treatment while they are at school. For more information: http://www.lifewatchv.com
Transplanting insulin-producing cells—One of the promising approaches in treating Type 1 diabetes is to transplant healthy insulin-producing beta cells into the pancreas. A new technique developed by Ben-Gurion University Prof. Smadar Cohen increases the survival and effectiveness of these transplanted cells. Her breakthrough approach, currently being tested on diabetic mice, involves surrounding the transplanted cells with a three-dimensional latticework of nurturing blood vessels. The biologically engineered tissue secretes growth hormones and helps cells communicate with one another.
Source: Excerpts of an article by Abigail Klein Leichman, www.israel21.c.org
All logos and trademarks in this site are property of their respective owner. All other materials are property of Bridges for Peace. Copyright © 2024.
Website Site Design by J-Town Internet Services Ltd. - Based in Jerusalem and Serving the World.
